Atlas Trials

Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Clinical trial NCT00513747 · TERMINATED

Trial details

NCT number
NCT00513747
Sponsor
Alliance for Clinical Trials in Oncology
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Leukemia
Start date
2008-01-01
Primary completion
2016-06-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.